gip/glp-1 drugs Understand GLP-1/GIP Dual Agonist Tirzepatide and Its Effect on Current Weight Loss Therapy GLP-1/GIP Receptor Agonists and Diabetic
Description
But they may cause side effects
The GLP-1 receptor agonist dulaglutide attenuates hepatic steatosis in obesity via a weight-independent mechanism
doi: 10.1111/apt.13662
Is Wegovy the same as Ozempic
Multiple injectable peptidic GLP-1R agonists are approved for the treatment of Type 2 diabetes mellitus (T2DM) ( 8 ), including liraglutide which is also approved for the treatment of obesity ( 9 )
